文献速递衰弱、肌少症与跌倒老年综合评估

SF-36与步速预测老年女性临床前移动障碍的比较

36-Item Short Form Survey (SF-36) Versus Gait Speed As Predictor of Preclinical Mobility Disability in Older Women: The Women's Health Initiative.
PubMed 文献 · J Am Geriatr Soc · 2018-02-10

该前瞻性队列研究纳入3587名65至79岁女性,比较自报SF-36身体功能指数与临床测量步速对临床前移动障碍(PCMD)的预测价值。结论认为步速识别PCMD风险优于SF-36,但监测移动性变化轨迹比单次测量更有预测价值。

要点

  • 步速下降者3年和6年发生PCMD的风险比分别为2.59和2.35。
  • SF-36身体功能下降者3年和6年发生PCMD的风险比分别为1.42和1.49。
  • 基线步速预测6年PCMD的AUC为0.713,SF-36为0.705,差异无统计学意义。

核心结论

  • 步速识别老年女性PCMD风险优于SF-36身体功能指数,但监测移动性变化轨迹比单次测量更有预测价值。

研究设计与样本

  • 基线(1993-1998年)及随访第1、3、6年评估步速和SF-36身体功能指数。

主要发现

  • 基线步速较慢和SF-36身体功能评分较低均与第3年和第6年PCMD风险升高相关(均P<.001)。
  • 步速下降者第3年发生PCMD的比值比为2.59,第6年为2.35。
  • SF-36身体功能下降者第3年发生PCMD的比值比为1.42,第6年为1.49。
  • 基线步速预测6年PCMD的AUC为0.713,SF-36为0.705,差异无统计学意义(P=.21)。
  • 纳入第二次时间点的测量可显著改善模型对PCMD的预测区分度(均P<.001)。

关键数值与推荐

  • PCMD定义为步速<1.0 m/s。
  • 步速下降者第3年发生PCMD的比值比为2.59,第6年为2.35。
  • SF-36身体功能下降者第3年发生PCMD的比值比为1.42,第6年为1.49。
  • 基线步速预测6年PCMD的AUC为0.713,SF-36为0.705(P=.21)。

临床怎么用

  • 在老年女性移动障碍风险评估中,可优先采用临床步速测量而非仅依赖自报SF-36。
  • 应动态监测步速和身体功能的变化轨迹,而非仅依靠单次评估。

局限性

  • 步速既作为预测因素又用于定义PCMD结局,可能限制结果的解释。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To compare the value of clinically measured gait speed with that of the self-reported Medical Outcomes Study 36-item Short-Form Survey Physical Function Index (SF-36 PF) in predicting future preclinical mobility disability (PCMD) in older women. DESIGN: Prospective cohort study. SETTING: Forty clinical centers in the United States. PARTICIPANTS: Women aged 65 to 79 enrolled in the Women's Health Initiative Clinical Trials with gait speed and SF-36 assessed at baseline (1993-1998) and follow-up Years 1, 3, and 6 (N = 3,587). MEASUREMENTS: Women were categorized as nondecliners or decliners based on changes (from baseline to Year 1) in gait speed and SF-36 PF scores. Logistic regression models were used to estimate incident PCMD (gait speed <1.0 m/s) at Years 3 and 6. Area under the receiver operating characteristic curve (AUC) was used to compare the predictive value of SF-36 PF with that of measured gait speed. RESULTS: Slower baseline gait speed and lower SF-36 PF scores were associated with higher adjusted odds of PCMD at Years 3 and 6 (all P < .001). For gait speed, decliners were 2.59 times as likely to have developed PCMD as nondecliners by Year 3 and 2.35 times as likely by Year 6. Likewise, for SF-36, decliners were 1.42 times as likely to have developed PCMD by Year 3 and 1.49 times as likely by Year 6. Baseline gait speed (AUC = 0.713) was nonsignificantly better than SF-36 (AUC = 0.705) at predicting PCMD over 6 years (P = .21); including measures at a second time point significantly improved model discrimination for predicting PCMD (all P < .001). CONCLUSION: Gait speed identified PCMD risk in older women better than the SF-36 PF did, although the results may be limited given that gait speed served as a predictor and to define the PCMD outcome. Nonetheless, monitoring trajectories of change in mobility are better predictors of future mobility disability than single measures.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Laddu DR, Wertheim BC, Garcia DO, et al. 36-Item Short Form Survey (SF-36) Versus Gait Speed As Predictor of Preclinical Mobility Disability in Older Women: The Women's Health Initiative. J Am Geriatr Soc. 2018. PMID: 29427503. doi:10.1111/jgs.15273

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。